In T1DM, insulin is administered subcutaneously to the systemic circulation, and as a consequence, it results in lower portal levels of insulin, as well as lower SHBG levels compared to PCOS [4, 43]. This evidence concerns the gene SHBG and polycystic ovary syndrome.